The Federal Agency for Disruptive Innovation (SPRIND) has announced the participants of the first SPRIND Challenge “A Quantum Leap for New Antiviral Agents”. From 45 applications from Germany and Europe, the jury...
The Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) is supporting the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg - an institution of the...
Nitric oxide (NO) occurs naturally in the human body as a messenger substance. It is considered an all-rounder, as it performs numerous important regulatory functions, including immune defense against pathogens. The...
The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They thereby wish to target...
It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland...
In the coronavirus pandemic, older people are particularly at risk from severe courses of COVID-19. However, other infectious diseases also affect them more than younger people. On the occasion of the International Day...
EMBL and the six Helmholtz Centers of the Research Field Health (Helmholtz Health) are expanding their collaboration. The two research organisations are cooperating to expand the frontiers of health research and advance...
